Methicillin resistant Staphylococcus aureus (MRSA) strains currently pose a major problem in many hospitals in the United Kingdom.' Some strains, most notably the strain of MRSA prevalent in the south east of England (EMRSA),2 spread rapidly between patients and hospital sites. 3 Other strains are epidemic in other parts of the country but are not so widespread or well documented. Once established, these strains can become a long term endemic problem.
The factors that contribute to epidemic spread have not been clearly established. MRSA strains tend to be resistant to numerous broad spectrum antibiotics,3 which may contribute to their survival in the hospital environment. Only a small proportion of MRSA, however, exhibit epidemic spread which suggests that factors other than antibiotic resistance may play a part.
We have shown previously that EMRSA produces both cell bound and free coagulase and that this characteristic is not shared universally with other MRSA.4 Other work has suggested an association between coagulase and another potential virulence factor, protein A.' In this paper we attempted to establish a relation between these two factors in several groups of S aureus.
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SOURCE OF STRAINS
United Kingdom Four groups of S aureus, each comprising 10 strains, were selected on the basis of differing antibiotic resistance characters. EMRSA strains represented the range of phage types and antibiotic resistance of the strain epidemic in the south east of England; (OMRSA) other methicillin resistant S aureus; (ORSA) methicillin sensitive but multiresistant S aureus, and (SSA) sensitive S aureus. International MRSA were requested from all the major phage typing centres in the world, and a collection of MRSA from international sources was assembled for survey purposes. From these, 27 sporadic MRSA strains from 11 different countries and 27 outbreak associated (epidemic) MRSA strains from 15 different countries were studied. The strains were specified as epidemic or sporadic by the sending laboratory. S aureus Wood 46 (NCTC 7121), a poor protein A producer, and S aureus Cowan I (NCTC 8530), a good protein A producer, were used as controls.
ESTIMATION OF PROTEIN A
Cell boundprotein A Staphylococci grown overnight in 3 ml of nutrient broth at 37°C were centrifuged at 3000 rpm for 15 minutes and resuspended in carbon-ate buffer (pH 9 pressed low levels of cell bound protein A, comparable with the levels observed in EMRSA. The non-epidemic strains generally exhibited high levels of protein A similar to most of the other United Kingdom S aureus tested. Slide coagulase test Twenty four of 27 (89%) of the epidemic strains gave strong positive results in the slide coagulase test ( figure) . A wider range of results were shown by the non-epidemic strains, 48% of which gave + /-, 1+, or 2+ reactions. Previously we reported that EMRSA gave strong positive results in the slide coagulase test but that other MRSA often gave weak results.4 A plot of cell bound protein A and strength of reaction in the slide coagulase test for each strain showed a cluster of epidemic strains with low cell bound protein A but strong slide coagulase reaction (figure). A vertical line at the 3 + reaction in the slide coagulase test score and a horizontal line at the RABC value of 4 divided the plot into strong and weak reactions for both tests. There was significant clustering of the epidemic strains in the quadrant representing strong coagulase but poor protein A production (X2 = 22-3, 3 df, p = 0-001).
Discussion
Some strains of MRSA give rise to outbreaks producing infection or colonisation, or both, but others do not. In terms of patient management it would be extremely useful to be able to distinguish strains that are potentially epidemic from non-epidemic or sporadic strains. The results of our study suggest that epidemic strains have properties which distinguish them from sporadic strains. The characters observed here, low levels of protein A and high levels of coagulase, are not absolutely definitive but may indicate potentially epidemic strains.
A variety of external factors influence protein A production6-9 and conditions in vivo may produce different results than in vitro situation studied here. No specific virulence factor has been attributed to pathogenic S aureus, and protein A seems to be only one of the many possible contributory factors. It has been suggested that deficiencies in protein A, or clumping factor, or both, have been responsible for containment of an MRSA strain within a unit.'0 Our results would seem to suggest otherwise, as EMRSA and other epidemic strains generally produce less protein A than the non-epidemic strains tested. Protein A production does not seem to be associated with antibiotic resistance. Methicillin resistance per se is not indicative of a lack of, or poor, protein A production, as has been previously suggested."
EMRSA possesses properties distinct from other non-outbreak associated strains of differing antibiotic Roberts, Gaston resistances within the United Kingdom but comparable with other epidemic strains from around the world. EMRSA and the international outbreak associated strains studied both expressed low levels of protein A and strong slide coagulase reactions. Two of the international sporadic strains gave similar results and were subsequently found to be similar to EMRSA in their antibiotic resistance profiles and phage types.
Initially we restricted our study to methicillin resistant strains in which the resistance provides a useful epidemiological marker. It will be necessary to extend the study to include methicillin sensitive epidemic and sporadic strains to determine whether this relation between protein A and coagulase applies to other epidemic strains.
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